• April 15, 2025

FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

In a landmark move, the FDA has announced plans...

author-avatar
Posted By transcell
  • September 27, 2016

An industry perspective on the FDA Modernization Act 2.0/3.0: potential next steps for sponsors to reduce animal use in drug development

Abstract Pharmaceutical developers are encouraged to adopt the best...

author-avatar
Posted By transcell
  • September 27, 2016

Vaccine testing without animal experiments?

Abstract Vaccines must provide effective protection against disease without...

author-avatar
Posted By transcell
  • September 27, 2016

Potency testing of cell and gene therapy products

Potency is one of the critical quality attributes of...

author-avatar
Posted By transcell
  • September 27, 2016

Precision oncology using ex vivo technology: a step towards individualised cancer care

Despite advances in cancer genomics and the increased use...

author-avatar
Posted By transcell